IP Group portfolio companies acquired by US firms
5th May 2021 08:07
(Sharecast News) - Intellectual property-based business investor IP Group said on Wednesday that two of its portfolio companies had been acquired by US-listed firms.
Read moreOxford Nanopore gets £195 in fresh funding ahead of float
4th May 2021 07:29
(Sharecast News) - Oxford Nanopore has raised £195m in new cash ahead of its planned stock market float expected later this year, the company's investor IP Group said.
Read moreIP Group portfolio business eyes LSE floatation
30th Mar 2021 07:53
(Sharecast News) - Intellectual property-based business developer IP Group said on Tuesday that portfolio company Oxford Nanopore Technologies had started the process of preparing for a potential initial public offering.
Read moreBuybacks make a comeback as crisis eases
10th Mar 2021 12:22
(Sharecast News) - UK companies have announced more than £2bn of share buybacks in 2021 with more in the pipeline, suggesting this means of returning cash to shareholders is on the way back.
Read moreIP Group's North American platform raises another $50m
10th Feb 2021 08:45
(Sharecast News) - Intellectual property-based business developer IP Group announced on Wednesday that its North American platform, IP Group, Inc., has secured an additional $50m (£36.5m) of funding, including $40m from a new US blue-chip institutional investor.
Read moreIP Group slumps as Invesco sells 61.9m shares
7th Jan 2021 08:18
(Sharecast News) - IP Group slid on Thursday after Invesco sold 61.9m shares in the company in a placing.
Read moreIP Group's Oxbiotica raises £36m in series B round
6th Jan 2021 08:25
(Sharecast News) - Intellectual property investor IP Group announced on Wednesday that its autonomous vehicle software portfolio company Oxbotica has raised £36m of new capital in a series B round, from both new and existing investors.
Read moreIP Group's Artios signs research deal with Merck
3rd Dec 2020 09:08
(Sharecast News) - IP Group said its Artios portfolio company had signed a research deal with Merck of Germany that could more than double the value of the investment company's stake.
Read moreIP Group portfolio firm Oxford Nanopore raises another £84.4m
13th Oct 2020 08:30
(Sharecast News) - Intellectual property-based business investor IP Group announced on Tuesday that its portfolio company Oxford Nanopore Technologies has raised an additional £84.4m of new capital from existing and new investors, including International Holdings Company (IHC) and RPMI Railpen.
Read moreIP Group portfolio business offloads cystic fibrosis treatment programme to Roche
7th Oct 2020 10:57
(Sharecast News) - Intellectual property company IP Group said on Wednesday that portfolio group Enterprise Therapeutics' TMEM16A cystic fibrosis treatment programme had been acquired by Swiss pharmaceutical giant Roche.
Read moreIP Group in 'even stronger' financial position after first half
5th Aug 2020 08:33
(Sharecast News) - IP Group reported net portfolio gains of £34.9m, or 3%, in its first half on Wednesday, with cash realisations rising to £113.7m from £7.1m a year earlier, exceeding investment by £76.9m.
Read moreIP Group's Oxford Nanopore partners with Downing Street on Covid-19 test rollout
3rd Aug 2020 09:08
(Sharecast News) - Intellectual property investor IP Group said on Monday that portfolio company Oxford Nanopore had partnered with the UK Government to roll out LamPORE, a new generation of Covid-19 test.
Read moreIP Group raises £52.4m from Ceres Power stake sale
14th Jul 2020 13:59
(Sharecast News) - IP Group has raised £52.4m by selling shares in Ceres Power, leaving it with a small stake in the clean energy company it invested in eight years ago.
Read moreIP Group day-to-day operations 'largely unaffected' by Covid-19
18th Jun 2020 08:11
(Sharecast News) - Intellectual property business IP Group said on Thursday that its day-to-day operations had been largely unaffected by the Covid-19 pandemic so far this year.
Read moreIP Group's Oxford Nanopore in advanced development on SARS Cov-2 test
22nd May 2020 07:23
(Sharecast News) - Intellectual property developer IP Group said its portfolio company Oxford Nanopore Technologies was in advanced development of a new generation of end-to-end test (assay) for the detection of the virus that causes Covid-19.
Read more